Anna Makowska
Overview
Explore the profile of Anna Makowska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makowska A, Kontny U, van Helden J, Hildebrandt B, Schuler H, Weiskirchen R
Cancer Med
. 2025 Feb;
14(3):e70422.
PMID: 39905741
Background: Human nasopharyngeal carcinoma (NPC) cell lines are in vitro model systems that are widely available, easy to handle, and provide an unlimited supply of material. They also bypass ethical...
2.
Makowska A, Kontny U, Liehr T, Weiskirchen R
Lab Invest
. 2024 Sep;
104(10):102124.
PMID: 39241616
No abstract available.
3.
Makowska A, Kontny U, Weiskirchen R
Br J Cancer
. 2024 Apr;
130(12):1885-1886.
PMID: 38664578
No abstract available.
4.
Makowska A, Weiskirchen R
Cells
. 2024 Apr;
13(7.
PMID: 38606998
Nasopharyngeal carcinoma (NPC) is a type of cancer that originates from the mucosal lining of the nasopharynx and can invade and spread. Although contemporary chemoradiotherapy effectively manages the disease locally,...
5.
Makowska A, Wahab L, Braunschweig T, Kapetanakis N, Vokuhl C, Denecke B, et al.
Oncotarget
. 2023 Aug;
14:782-787.
PMID: 37646784
No abstract available.
6.
Makowska A, Saczewski F, Bednarski P, Gdaniec M, Balewski L, Warmbier M, et al.
Molecules
. 2022 Nov;
27(21).
PMID: 36363982
A series of copper(II) complexes of 2-imino-2-chromen-3-yl-1,3,5-triazines , 3-(benzoxazol-2-yl)-2-chromen-2-imines , and 3-(benzothiazol-2-yl)-2-chromen-2-imines were obtained by reacting of appropriate 2-iminocoumarin ligands , , and with 3-fold molar excess of copper(II) chloride....
7.
Romer T, Franzen S, Kravets H, Farrag A, Makowska A, Christiansen H, et al.
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267570
Nasopharyngeal carcinoma (NPC) in children and young adults has been treated within two consecutive prospective trials in Germany, the NPC-91 and the NPC-2003 study of the German Society of Pediatric...
8.
Makowska A, Lelabi N, Nothbaum C, Shen L, Busson P, Tran T, et al.
Cells
. 2021 Sep;
10(9).
PMID: 34572108
Background: Nasopharyngeal carcinoma (NPC) in endemic regions and younger patients is characterized by a prominent lymphomononuclear infiltration. Radiation is the principal therapeutic modality for patients with NPC. Recent data suggest...
9.
Makowska A, Meier S, Shen L, Busson P, Baloche V, Kontny U
Cancer Immunol Immunother
. 2020 Aug;
70(2):323-336.
PMID: 32737537
Background: Nasopharyngeal carcinoma (NPC) is a highly malignant epithelial cancer linked to Epstein-Barr virus (EBV) infection. Tumors are characterized by a lymphomononuclear infiltrate and the number of natural killer (NK)...
10.
Baloche V, Ferrand F, Makowska A, Even C, Kontny U, Busson P
Expert Opin Ther Targets
. 2020 Apr;
24(6):545-558.
PMID: 32249657
: Nasopharyngeal carcinoma (NPC) is a major public health problem in several countries, especially those in Southeast Asia and North Africa. In its typical poorly differentiated form, the Epstein-Barr virus...